The SURMOUNT-1 trial (N=2,539), published in the New England Journal of Medicine in 2022 (DOI: 10.1056/NEJMoa2206038), evaluated tirzepatide at 5mg, 10mg, and 15mg weekly doses versus placebo in adults with obesity or overweight
7.3.4 Clinical implications and problems The potential of probiotics as a therapeutic strategy for mitigating BBB dysfunction and cognitive decline is supported by promising preclinical findings, but clinical evidence remains limited (Sproten et al., 2024)
This data proves that the profound fatigue and exercise intolerance in ME/CFS are intrinsically linked to the destruction of autonomic small nerve fibers
Semaglutide is packaged in a sealed laboratory vial designed to help maintain product integrity during shipping and storage
Together, we can explore whether glutathione therapy is the right path for you and design a skin-brightening plan that truly works.
Rimonabant: from RIO to Ban